Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis

被引:141
作者
Afonja, O
Juste, D
Das, S
Matsuhashi, S
Samuels, HH
机构
[1] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA
[3] Saga Med Sch, Dept Internal Med, Saga 8498501, Japan
关键词
PDCD4; apoptosis; retinoic acid receptor; breast cancer; cell cycle;
D O I
10.1038/sj.onc.1207983
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growth of human breast tumor cells is regulated through signaling involving cell surface growth factor receptors and nuclear receptors of the steroid/thyroid/retinoid receptor gene family. Retinoic acid receptors (RARs), members of the steroid/thyroid hormone receptor gene family, are ligand-dependent transcription factors, which have in vitro and in vivo growth inhibitory activity against breast cancer cells. RAR-agonists inhibit the proliferation of many human breast cancer cell lines, particularly those whose growth is stimulated by estradiol (E2) or growth factors. Additionally, RAR-agonists and synthetic retinoids such as Ferentinide have been shown to induce apoptosis in malignant breast cells but not normal breast cells. To better de. ne the genes involved in RAR-mediated growth inhibition of breast cancer cells, we used oligonucleotide microarray analysis to create a database of genes that are potentially regulated by RAR-agonists in breast cancer cells. We found that PDCD4 (programmed cell death 4), a tumor suppressor gene presently being evaluated as a target for chemoprevention, was induced about three-fold by the RARalpha-selective agonist Am580, in T-47D breast cancer cells. RAR pan-agonists and Am580, but not retinoid X receptors (RXR)-agonists, stimulate the expression of PDCD4 in a wide variety of retinoid-inhibited breast cancer cell lines. RAR-agonists did not induce PDCD4 expression in breast cancer cell lines, which were not growth inhibited by retinoids. We also observed that antiestrogen and the HER-2/neu antagonist, Herceptin (Trastuzumab), also induced PDCD4 expression in T-47D cells, suggesting that PDCD4 may play a central role in growth inhibition in breast cancer cells. Transient overexpression of PDCD4 in T-47D (ER+, RAR(+)) and MDA-MB-231 (ER-, RAR(-)) cells resulted in apoptotic death, suggesting a role for PDCD4 in mediating apoptosis in breast cancer cells. PDCD4 protein expression has previously been reported in small ductal epithelium of normal breast. To date, there has been no report of induction of PDCD4 expression by RAR-agonists, antiestrogen or HER2/neu antagonist in breast cancer cells and its potential role in apoptosis in these cells.
引用
收藏
页码:8135 / 8145
页数:11
相关论文
共 63 条
  • [1] RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition
    Afonja, O
    Raaka, BM
    Huang, A
    Das, S
    Zhao, XY
    Helmer, E
    Juste, D
    Samuels, HH
    [J]. ONCOGENE, 2002, 21 (51) : 7850 - 7860
  • [2] RETINOIC ACID RECEPTORS AND RETINOID X-RECEPTORS - INTERACTIONS WITH ENDOGENOUS RETINOIC ACIDS
    ALLENBY, G
    BOCQUEL, MT
    SAUNDERS, M
    KAZMER, S
    SPECK, J
    ROSENBERGER, M
    LOVEY, A
    KASTNER, P
    GRIPPO, JF
    CHAMBON, P
    LEVIN, AA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 30 - 34
  • [3] AMOS B, 1990, METHOD ENZYMOL, V190, P217
  • [4] Azzoni L, 1998, J IMMUNOL, V161, P3493
  • [5] Molecular targets for breast cancer therapy and prevention
    Bange, J
    Zwick, E
    Ullrich, A
    [J]. NATURE MEDICINE, 2001, 7 (05) : 548 - 552
  • [6] The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA
    Böhm, M
    Sawicka, K
    Siebrasse, JP
    Brehmer-Fastnacht, A
    Peters, R
    Klempnauer, KH
    [J]. ONCOGENE, 2003, 22 (31) : 4905 - 4910
  • [7] Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
    Chen, Y
    Knösel, T
    Kristiansen, G
    Pietas, A
    Garber, ME
    Matsuhashi, S
    Ozaki, I
    Petersen, I
    [J]. JOURNAL OF PATHOLOGY, 2003, 200 (05) : 640 - 646
  • [8] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [9] Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
    Cmarik, JL
    Min, HZ
    Hegamyer, G
    Zhan, SN
    Kulesz-Martin, M
    Yoshinaga, H
    Matsuhashi, S
    Colburn, NH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) : 14037 - 14042
  • [10] Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300
    Dietze, EC
    Caldwell, LE
    Marcom, K
    Collins, SJ
    Yee, L
    Swisshelm, K
    Hobbs, KB
    Bean, GR
    Seewaldt, VL
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (01) : 23 - 40